AVGO Q1 2026 Earnings Slight EPS Miss Amid Mixed Signals Compass Therapeutics Q1 2026 Earnings Narrowed Loss and Positive Surprise as Pipeline Progress Continues Recursion Pharmaceuticals RXRX Q1 2026 Earnings Narrower Loss Surprises Market but Stock Dips on PreRevenue Status UHT Q1 2026 Earnings EPS Beats in Absence of Consensus Shares Edge Higher Targa Resources Q1 2026 Earnings EPS Misses Estimates Amid Operational Strength JOE Q1 2026 Earnings EPS of 024 Reported Stock Sees Slight Decline